$BNTX &amp; $PFE, which are jointly developing the COVID-19 vaccine, “BNT162”, announced today the Germany has approved the Phase 1/2 clinical trial for “BNT162” in the first-in-human trial (pre-clinical studies have been completed).
#biotech #COVID19 #coronavirus https://t.co/ccTaKnHUkn